Cardiac Output Monitoring With Estimated Continuous Cardiac Output (esCCO)

Clinical Trial Description

Using appropriate statistical methods the cardiac index values obtained via pulse wave transit time with esCCO system will be compared with traditional transpulmonary thermodilution technique. ;

Study Design

Related Conditions & MeSH terms

Pulse Wave Analysis

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02922478` - Role of Comorbidities in Chronic Heart Failure Study
	Completed	`NCT02493296` - The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
	Recruiting	`NCT03521739` - Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events

See also

Status

Clinical Trial

Phase

Completed

NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study

Completed

NCT02493296 - The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study

Recruiting

NCT03521739 - Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02352324
Study type	Interventional
Source	Northern State Medical University
Contact
Status	Completed
Phase	N/A
Start date	June 2014
Completion date	June 2014

Cardiac Output Monitoring With Estimated Continuous Cardiac Output (esCCO) vs. Transpulmonary Thermodilution (TPTD)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms